The in silico studies, which were performed by applying molecular target prediction tools, highlighted human carbonic anhydrase II (hCA-II) and XII (hCA-XII) enzymes, related to several pathologies (hypertension, metabolic syndromes, edema, etc.)as potential targets of the identified phytochemicals. This evidence concerns the gene CA2 and hypertensive disorder.